Cost Analysis of Intravitreal Aflibercept vs Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 34042958.
- Also identified by DOI 10.1001/jamaophthalmol.2021.1565 and PMC identifier 8160925.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This economic evaluation study compares the costs of intravitreal injections of aflibercept, 2 mg, vs pars plana vitrectomy plus panretinal photocoagulation for nonclearing vitreous hemorrhage secondary to proliferative diabetic retinopathy.
Medical subject headings
- Diabetes Mellitus
- Diabetic Retinopathy